P75 neurotrophin receptor as a therapeutic target for drug development to treat neurological diseases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

P75 neurotrophin receptor as a therapeutic target for drug development to treat neurological diseases

Published:2022-09-07 Issue:8 Volume:56 Page:5299-5318
ISSN:0953-816X
Container-title:European Journal of Neuroscience
language:en
Short-container-title:Eur J of Neuroscience

Author:

Xiong Liu‐Lin¹²³,Chen Li¹,Deng Isaac Bul²,Zhou Xin‐Fu²,Wang Ting‐Hua¹^ORCID

Affiliation:

1. Institute of Neurological Disease West China Hospital, Sichuan University Chengdu China

2. Clinical and Health Sciences University of South Australia Adelaide South Australia Australia

3. Department of Anesthesiology Affiliated Hospital of Zunyi Medical University Zunyi China

Funder

Science and Technology Program of Guizhou Province

National Natural Science Foundation of China

Publisher

Wiley

Subject

General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejn.15810

Reference149 articles.

1. A Genetic Variant of the Sortilin 1 Gene is Associated with Reduced Risk of Alzheimer’s Disease

2. Neurotrophin signaling: many exciting surprises!

3. Chronic and Acute Models of Retinal Neurodegeneration TrkA Activity Are Neuroprotective whereas p75NTR Activity Is Neurotoxic through a Paracrine Mechanism

4. GDNF gene delivery via the p75NTR receptor rescues injured motor neurons

5. p75NTR Is Positively Promiscuous

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dysregulation of neurotrophin expression in prefrontal cortex and nucleus basalis magnocellularis during and after adolescent intermittent ethanol exposure;Alcohol;2024-11

2. Neurotrophin peptidomimetics for the treatment of neurodegenerative diseases;Drug Discovery Today;2024-09

3. The potential role of the p75 receptor in schizophrenia: neuroimmunomodulation and making life or death decisions;Brain, Behavior, & Immunity - Health;2024-07

4. Advances in Nanomedicines: A Promising Therapeutic Strategy for Ischemic Cerebral Stroke Treatment;Nanomedicine;2024-03-29

5. 14–3-3ε: a protein with complex physiology function but promising therapeutic potential in cancer;Cell Communication and Signaling;2024-01-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3